Hookipa Biotech AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hookipa Biotech AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10682
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hookipa Biotech AG (Hookipa) is a biotechnology company that develops vaccines and next-generation immunotherapeutics for the prevention and treatment of cancer and infectious diseases. The company’s lead product candidate include HB101 vaxwave, a vaccine under development for immunization against cytomegalovirus; HB201 for the treatment of human papilloma virus, and others. It uses its proprietary immunotherapy technology vaxwave that is used to develop a new class of cancer immunotherapeutics and vaccines. Hookipa’s vaxwave uses a replication-defective viral vector to develop prophylactic and therapeutic vaccines to treat cancer and infectious diseases. The company’s vaxwave-based immunotherapy can be applied repeatedly to enhance the immune system against diseases where B-cell and T-cell immune responses are required. Hookipa is headquartered in Vienna, Austria.

Hookipa Biotech AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hookipa Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Hookipa Biotech Raises USD58.8 Million in Series C Financing 10
Hookipa Biotech Raises US$27 Million In Series B Financing 12
Licensing Agreements 14
Gilead Sciences Enters into Licensing Agreement with Hookipa Biotech 14
Hookipa Biotech AG – Key Competitors 15
Hookipa Biotech AG – Key Employees 16
Hookipa Biotech AG – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Oct 18, 2017: Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors 18
Apr 19, 2017: Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech 19
Apr 19, 2017: Hookipa Biotech appoints CFO 20
Product News 21
May 26, 2017: Hookipa Biotech Announces Nature Communications Publication Showing TheraT Turns Cold Tumors Hot 21
05/15/2018: New Insights into Hookipa’s TheraT Replicating Viral Vector Platform Published in Immunity 22
03/06/2017: Dr Igor Matushansky Appointed Global Head, Research and Development of Hookipa Biotech 23
01/09/2017: Hookipa Biotech Announces Publication in Clinical and Vaccine Immunology Highlighting Vaxwave as an Effective Viral Vector for Vaccination against Congenital Cytomegalovirus Infections 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Key Facts 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hookipa Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hookipa Biotech AG, Deals By Therapy Area, 2012 to YTD 2018 8
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hookipa Biotech Raises USD58.8 Million in Series C Financing 10
Hookipa Biotech Raises US$27 Million In Series B Financing 12
Gilead Sciences Enters into Licensing Agreement with Hookipa Biotech 14
Hookipa Biotech AG, Key Competitors 15
Hookipa Biotech AG, Key Employees 16

List of Figures
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Hookipa Biotech AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Campbell Soup Company:企業の戦略・SWOT・財務情報
    Campbell Soup Company - Strategy, SWOT and Corporate Finance Report Summary Campbell Soup Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The GPT Group:企業の戦略・SWOT・財務情報
    The GPT Group - Strategy, SWOT and Corporate Finance Report Summary The GPT Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Phoenix Children’s Hospital-医療機器分野:企業M&A・提携分析
    Summary Phoenix Children's Hospital (PCH) is a healthcare center that provides medical services. The center’s services include anestesiology, dermatology, dermatology, child protection, bone marrow transplants, adolescent medicine, critical care, emergency medicine, developmental paediatrics and fet …
  • HDFC Bank Ltd:企業の戦略・SWOT・財務情報
    HDFC Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary HDFC Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Eni SpA (ENI):企業の財務・戦略的SWOT分析
    Eni SpA (ENI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Korea Research Institute of Chemical Technology:製薬・医療:M&Aディール及び事業提携情報
    Summary Korea Research Institute of Chemical Technology (KRICT) is a chemical institute that develops chemical process technologies. The institute provides green technology, chemical materials, drug candidates, and chemistry based fusion technologies. Its green chemistry research includes petroleum …
  • Heineken NV:企業の戦略・SWOT・財務分析
    Heineken NV - Strategy, SWOT and Corporate Finance Report Summary Heineken NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Mahle GmbH:企業の戦略・SWOT・財務情報
    Mahle GmbH - Strategy, SWOT and Corporate Finance Report Summary Mahle GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Rockwool International AS:戦略・SWOT・企業財務分析
    Rockwool International AS - Strategy, SWOT and Corporate Finance Report Summary Rockwool International AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cell Medica Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cell Medica Ltd (Cell Medica), formerly Immunocode Ltd manufactures and commercializes cellular products. The company uses various technology platforms such as chimeric antigen receptor (CAR), Dominant T cell receptor (TCR), PENTRA Antibody technology and NKT cell platform for manufacturing …
  • Leadiant Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Leadiant Biosciences Inc (Leadiant Biosciences) a subsidiary of Sigma-Tau SpA is a pharmaceutical company that discovers and develops novel medicines. The company offers products such as Cystaran, Carnitor, Matulane, Adagen, Abelcet, DepoCyt, ProXeed Plus, VSL and Colief products. It offers …
  • Epic Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Epic Sciences Inc (Epic Sciences) focuses to develop novel diagnostics for personalized treatment of cancer. The company develops AR-V7 test to identify and molecularly characterize circulating tumor cells in a blood sample. It also offers biopharma solutions such as resistance to AR signali …
  • Axela Inc-製薬・医療分野:企業M&A・提携分析
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • Islami Bank Bangladesh Ltd
    Islami Bank Bangladesh Ltd - Strategy, SWOT and Corporate Finance Report Summary Islami Bank Bangladesh Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cranswick plc:企業の戦略・SWOT・財務情報
    Cranswick plc - Strategy, SWOT and Corporate Finance Report Summary Cranswick plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • International Paper APPM Limited:企業の戦略・SWOT・財務情報
    International Paper APPM Limited - Strategy, SWOT and Corporate Finance Report Summary International Paper APPM Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Sojitz Corp (2768):石油・ガス:M&Aディール及び事業提携情報
    Summary Sojitz Corp (Sojitz) is a diversified general trading group. The group through its subsidiaries and affiliates holds interest in machinery; energy and metals; chemicals and functional materials; and consumer lifestyle businesses. It distributes automobiles and aircraft; develops power projec …
  • Medrobotics Corp:製品パイプライン分析
    Summary Medrobotics Corp (Medrobotics), formerly Cardioborobotics Inc is a medical device company that develops flexible robot platforms for single-site surgical and interventional applications. The company provides flex robotic systems and flex retractor systems. Its flexible robot platform contain …
  • Laboratoires Pierre Fabre SA:企業の戦略的SWOT分析
    Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Shutterfly Inc (SFLY):企業の財務・戦略的SWOT分析
    Shutterfly Inc (SFLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆